Biomerica raises $2.23 million in private placement of 1.39 million shares at $1.60
Biomerica agreed on August 20, 2026 to sell 1,393,705 common shares at $1.60 each to institutional and individual investors, including B. Riley Principal Capital and some directors and executive officers, for gross proceeds of about $2.23 million; the deal closed August 26, 2026. The filing also gives B. Riley purchasers a board designation right while they hold at least 10% of voting power, and requires registration of the resale of the shares, with liquidated damages if deadlines are missed.
Key points
- 1,393,705 shares sold at $1.60 per share, about $2.23 million gross proceeds
- Closing occurred August 26, 2026; agreement dated August 20, 2026
- B. Riley purchasers may designate one board representative while holding at least 10% of voting power
- Directors and certain officers face 180-day lock-up; company must file resale registration within 30 days of closing
The filing
Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 26, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.